OptiNose (OPTN) Appoints R. John Fletcher to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. LMT
6. RXST
7. SPY
8. SPGI
9. RIVN
10. CMPS

Go back to OptiNose (OPTN) Appoints R. John Fletcher to its Board

Optinose Announces Appointment of R. John Fletcher to the Board

April 26, 2022 8:00 AM EDT

YARDLEY, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it has appointed R. John Fletcher to its Board of Directors as a Class III director.

"We are pleased to welcome John to the Optinose Board of Directors," stated Joe Scodari,... More